Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Webcast

NANOBIOTIX to Participate in a Fireside Chat at the Jefferies London Healthcare Conference


Regulatory News:

NANOBIOTIX (Euronext: NANO ? NASDAQ: NBTX ? the ??Company''), a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, today announced that Laurent Levy, Chief Executive Officer, will participate in a fireside chat at the Jefferies London Healthcare Conference at 3:40 PM GMT / 10:40 AM EST on Tuesday, November 16, 2021.

The fireside chat will be webcast live from the Events section of the company's website at www.nanobiotix.com. A replay of the webcast will be archived and available for one month following the event.

About NANOBIOTIX

Nanobiotix is a late-stage clinical biotechnology company pioneering disruptive, physics-based therapeutic approaches to revolutionize treatment outcomes for millions of patients; supported by people committed to making a difference for humanity. The company's philosophy is rooted in the concept of pushing past the boundaries of what is known to expand possibilities for human life. Incorporated in 2003, Nanobiotix is headquartered in Paris, France. The company also has subsidiaries in Cambridge, Massachusetts (United States), France, Spain, and Germany. Nanobiotix has been listed on the regulated market of Euronext in Paris since 2012 and on the Nasdaq Global Select Market in New York City since December 2020. Nanobiotix is the owner of more than 30 umbrella patents associated with three (3) nanotechnology platforms with applications in 1) oncology; 2) bioavailability and biodistribution; and 3) disorders of the central nervous system. The company's resources are primarily devoted to the development of its lead product candidate? NBTXR3 ?which is the product of its proprietary oncology platform and has already achieved market authorization in Europe for the treatment of patients with soft tissue sarcoma under the brand name Hensify®. For more information about Nanobiotix, visit us at www.nanobiotix.com or follow us on LinkedIn and Twitter.


These press releases may also interest you

at 08:50
David and Marta Hall, former executive officers and controlling stockholders of Velodyne Lidar, Inc. ("Velodyne Lidar" or the "Company"), today announced that they have filed a lawsuit in the United States Superior Court of California against...

at 08:49
The rapid spread of COVID-19, a disease caused by the SARS-CoV-2 virus, has created a public health crisis around the world. Early COVID-19 detection and isolation are key for controlling disease transmission and protecting vulnerable populations....

at 08:48
ISLE 2022, China's Top Exhibition for Smart Display, AV Integrated System and LED, just announced two-month postponement to April. The event was first scheduled for February 22-24, 2022. In accordance with "COVID Prevention and Control Working Plan...

at 08:47
Madwire®, together with their client, Agfinity, landed a first place NAMA (National Agri-Marketing Association) award for internet website serving agribusiness. Madwire designed the website for Agfinity and it is built on their Woo 360 platform....

at 08:46
Businesses around the world were rocked with COVID-19, however, great innovation in both physical and digital storefronts came along. MobiDev experts defined the most important healthcare technology trends that can impact the retail industry in 2022....

at 08:45
Water Ways Technologies Inc. (FRA: WWT) ("Water Ways" or the "Company"), a global provider of Israeli-based agriculture technology, providing water irrigation solutions to agricultural producers, announces that it has today agreed to issue to an...



News published on 3 november 2021 at 16:30 and distributed by: